Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic
Ive Lima Souza, Ítalo Fernandes, Patrícia Taranto, Antônio C. Buzaid, Gustavo Schvartsman
Topics & Concepts
NivolumabIpilimumabPandemicCoronavirus disease 2019 (COVID-19)MedicineVirologyPneumoniaCoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonitis2019-20 coronavirus outbreakImmune systemDiseaseImmunologyImmunotherapyInfectious disease (medical specialty)LungInternal medicineOutbreakCancer Immunotherapy and BiomarkersCOVID-19 Clinical Research StudiesCOVID-19 and healthcare impacts